Cargando…

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B

The coexistence of HBV infection and hepatic steatosis is a novel characteristic of liver disease. Silibinin capsules (SC) is a silybin-phospholipid complex containing silybin as the bioactive component, which exerts a remarkable biological effect on various liver diseases, including nonalcoholic fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Duo-Duo, Wang, You-Juan, Wang, Meng-Lan, Chen, En-Qiang, Tao, Ya-Chao, Zhang, Dong-Mei, Tang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804199/ https://www.ncbi.nlm.nih.gov/pubmed/33436935 http://dx.doi.org/10.1038/s41598-020-80709-z

Ejemplares similares

Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study
por: Tao, Ya-Chao, et al.
Publicado: (2018)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model
por: Akbari-Kordkheyli, Vahid, et al.
Publicado: (2019)

Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
por: Li, Yu-Cheng, et al.
Publicado: (2018)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Effect modification of hepatitis B viral load on the association between metabolic risk factors and hepatic steatosis
por: Shi, Michelle Y., et al.
Publicado: (2023)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Anti-hepatitis, antioxidant activities and bioactive compounds of Dracocephalum heterophyllum extracts
por: Shi, Qiang-Qiang, et al.
Publicado: (2016)

Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B
por: Wang, Fa-Da, et al.
Publicado: (2022)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
por: Li, Mao, et al.
Publicado: (2016)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Hepatic steatosis in patients with acromegaly
por: Koutsou‐Tassopoulou, Andreani, et al.
Publicado: (2019)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells
por: Verdura, Sara, et al.
Publicado: (2022)

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism
por: Pan, Qin, et al.
Publicado: (2017)

Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease
por: Veltkamp, Claudia, et al.
Publicado: (2022)

Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway
por: Liu, Yayun, et al.
Publicado: (2019)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020)

Multiple hepatic pseudotumors: A rare presentation of hepatic steatosis
por: Fujikawa, Hirohisa, et al.
Publicado: (2020)

Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Levine, Joshua A., et al.
Publicado: (2021)

Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
por: Lazo, Mariana, et al.
Publicado: (2010)

The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Hepatic DKK1-driven steatosis is CD36 dependent
por: Yang, Zhen, et al.
Publicado: (2022)

Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B
por: Jin, Xi, et al.
Publicado: (2012)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Hepatic Steatosis
por: Zheng, Rui-dan, et al.
Publicado: (2013)

Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis
por: Zhou, Peng, et al.
Publicado: (2014)

Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis
por: Seidemann, Lena, et al.
Publicado: (2021)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis
por: Guo, Xing-Ya, et al.
Publicado: (2017)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C
por: Huang, Chao-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_acjhm93gl89drrennjg57sb0kc